{"transactions":[{"id":959375,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)*","published_at":"2025-12-23T14:41:08.000Z","date":"2025-12-19","kind":"grant","planned":false,"acquired":true,"shares":1000000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2484809,"derivative":{"exercise_price":0.83,"exercise_date":"2025-12-19","expiration_date":"2030-12-19","underlying":"Common Stock","underlying_shares":1000000},"source":{"system":"sec-edgar","filing":"0001829126-25-010253","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625010253/ownership.xml","form_type":"4"}},{"id":1030378,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-09-30T21:01:48.000Z","date":"2025-09-29","kind":"grant","planned":false,"acquired":true,"shares":36459,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":191252,"source":{"system":"sec-edgar","filing":"0001829126-25-007777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625007777/ownership.xml","form_type":"4"}},{"id":1041274,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T21:08:34.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1484809,"derivative":{"exercise_price":0.96,"exercise_date":"2025-09-12","expiration_date":"2030-08-29","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001829126-25-007373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625007373/ownership.xml","form_type":"4"}},{"id":1041273,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-12T21:08:34.000Z","date":"2025-09-12","kind":"grant","planned":false,"acquired":true,"shares":203125,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1384809,"derivative":{"exercise_price":0.96,"exercise_date":"2025-09-12","expiration_date":"2030-08-29","underlying":"Common Stock","underlying_shares":203125},"source":{"system":"sec-edgar","filing":"0001829126-25-007373","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625007373/ownership.xml","form_type":"4"}},{"id":1240213,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-27T21:33:38.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":919184,"derivative":{"exercise_price":2.95,"exercise_date":"2025-02-26","expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001829126-25-001254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625001254/ownership.xml","form_type":"4"}},{"id":1240212,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-27T21:33:38.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":654363,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments based on the satisfaction of certain performance criteria for each of the annual periods ending June 30, 2024, 2025 and 2026. The performance criteria for the period ending June 30, 2024 were met, resulting in the vesting of options to purchase 218,121 shares."}],"balance_after":794184,"derivative":{"exercise_price":0.894,"expiration_date":"2034-06-30","underlying":"Common Stock","underlying_shares":654363},"source":{"system":"sec-edgar","filing":"0001829126-25-001254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625001254/ownership.xml","form_type":"4"}},{"id":1240211,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-02-27T21:33:38.000Z","date":"2025-02-26","kind":"grant","planned":false,"acquired":true,"shares":139821,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":139821,"derivative":{"exercise_price":0.894,"exercise_date":"2025-02-26","expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":139821},"source":{"system":"sec-edgar","filing":"0001829126-25-001254","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625001254/ownership.xml","form_type":"4"}},{"id":1281539,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-02-05T20:17:26.000Z","date":"2025-02-04","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":3.1,"value":3100.0,"ownership":{"direct":true},"balance_after":155793,"source":{"system":"sec-edgar","filing":"0001829126-25-000724","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000724/ownership.xml","form_type":"4"}},{"id":1283936,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-02-04T22:05:25.000Z","date":"2025-02-04","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.98,"value":2980.0,"ownership":{"direct":true},"balance_after":154793,"source":{"system":"sec-edgar","filing":"0001829126-25-000672","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000672/ownership.xml","form_type":"4"}},{"id":1291682,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-29T22:26:11.000Z","date":"2024-11-07","kind":"grant","planned":false,"acquired":true,"shares":262500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":262500,"derivative":{"exercise_price":0.94,"exercise_date":"2024-11-07","expiration_date":"2029-08-26","underlying":"Common Stock","underlying_shares":262500},"source":{"system":"sec-edgar","filing":"0001829126-25-000544","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000544/ownership.xml","form_type":"5"}},{"id":1291681,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-01-29T22:26:11.000Z","date":"2024-12-20","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.75,"value":2750.0,"ownership":{"direct":true},"balance_after":149293,"source":{"system":"sec-edgar","filing":"0001829126-25-000544","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000544/ownership.xml","form_type":"5"}},{"id":1291677,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-01-29T22:22:23.000Z","date":"2025-01-28","kind":"purchase","planned":false,"acquired":true,"shares":1500,"price":2.7,"value":4050.0,"ownership":{"direct":true},"balance_after":153793,"source":{"system":"sec-edgar","filing":"0001829126-25-000542","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000542/ownership.xml","form_type":"4"}},{"id":1295379,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-01-24T21:55:25.000Z","date":"2025-01-23","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":2.7,"value":2700.0,"ownership":{"direct":true},"balance_after":152293,"source":{"system":"sec-edgar","filing":"0001829126-25-000368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000368/ownership.xml","form_type":"4"}},{"id":1295378,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2025-01-24T21:55:25.000Z","date":"2025-01-13","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":2.5,"value":5000.0,"ownership":{"direct":true},"balance_after":151293,"source":{"system":"sec-edgar","filing":"0001829126-25-000368","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912625000368/ownership.xml","form_type":"4"}},{"id":1379288,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-10-30T14:55:00.000Z","date":"2024-10-28","kind":"purchase","planned":false,"acquired":true,"shares":500,"price":2.19,"value":1095.0,"ownership":{"direct":true},"balance_after":148293,"source":{"system":"sec-edgar","filing":"0001829126-24-007091","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624007091/ownership.xml","form_type":"4"}},{"id":1432269,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-08-15T20:25:25.000Z","date":"2024-08-13","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.95,"value":950.0,"ownership":{"direct":true},"balance_after":147793,"source":{"system":"sec-edgar","filing":"0001829126-24-005573","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624005573/ownership.xml","form_type":"4"}},{"id":1465511,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-07-01T17:47:49.000Z","date":"2024-06-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":1.75,"value":1750.0,"ownership":{"direct":true},"balance_after":146793,"source":{"system":"sec-edgar","filing":"0001829126-24-004517","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624004517/ownership.xml","form_type":"4"}},{"id":1471767,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-06-21T15:21:42.000Z","date":"2024-06-18","kind":"purchase","planned":false,"acquired":true,"shares":1619,"price":0.71,"value":1149.49,"ownership":{"direct":true},"balance_after":145793,"source":{"system":"sec-edgar","filing":"0001829126-24-004353","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624004353/ownership.xml","form_type":"4"}},{"id":1481769,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-06-12T17:19:52.000Z","date":"2024-06-10","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":0.62,"value":620.0,"ownership":{"direct":true},"balance_after":144174,"source":{"system":"sec-edgar","filing":"0001829126-24-004108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624004108/ownership.xml","form_type":"4"}},{"id":1481768,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock","published_at":"2024-06-12T17:19:52.000Z","date":"2024-06-10","kind":"purchase","planned":false,"acquired":true,"shares":2000,"price":0.65,"value":1300.0,"ownership":{"direct":true},"balance_after":143174,"source":{"system":"sec-edgar","filing":"0001829126-24-004108","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912624004108/ownership.xml","form_type":"4"}},{"id":1764257,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common stock warrants","published_at":"2023-10-05T16:08:46.000Z","date":"2022-09-16","kind":"purchase","planned":false,"acquired":true,"shares":2500,"price":0.4,"value":1000.0,"ownership":{"direct":true},"balance_after":2500,"derivative":{"exercise_price":4.15,"exercise_date":"2022-09-19","expiration_date":"2025-09-19","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001829126-23-006449","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912623006449/ownership.xml","form_type":"4"}},{"id":2153889,"issuer":{"id":8197,"kind":"organization","name":"Nexalin Technology, Inc."},"owners":[{"id":70880,"kind":"person","name":"Owens David","position":1,"cik":"0001916664","reported_name":"Owens David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2022-09-20T18:05:43.000Z","date":"2022-09-16","kind":"purchase","acquired":true,"shares":2500,"price":4.15,"value":10375.0,"ownership":{"direct":true},"balance_after":141174,"source":{"system":"sec-edgar","filing":"0001829126-22-017005","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527352/000182912622017005/ownership.xml","form_type":"4"}}]}